You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 12, March 22/29, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (18)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Men's Health, Other
 •Women's Health, Other
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic

The Role of X Inactivation and Cellular Mosaicism in Women's Health and Sex-Specific Diseases

Barbara R. Migeon, MD

JAMA. 2006;295:1428-1433.

Sex-specific manifestations of disease are most often attributed to differences in the reproductive apparatus or in life experiences. However, a good deal of sex differences in health issues have their origins in the genes on the sex chromosomes themselves and in X inactivation—the developmental program that equalizes their expression in males and females. Most females are mosaics, having a mixture of cells expressing either their mother's or father's X-linked genes. Often, cell mosaicism is advantageous, ameliorating the deleterious effects of X-linked mutations and contributing to physiological diversity. As a consequence, most X-linked mutations produce male-only diseases. Yet, in some cases the dynamic interactions between cells in mosaic females lead to female-specific disease manifestations.


Author Affiliations: The McKusick-Nathans Institute of Genetic Medicine and Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.


RELATED LETTERS

Maternal Age–Based Prenatal Genetic Testing
Robert Resta
JAMA. 2006;296(8):930.
EXTRACT | FULL TEXT  

X Inactivation and Cellular Mosaicism—Reply
Barbara R. Migeon
JAMA. 2006;296(8):931.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Supporting Family Adaptation to Presymptomatic and "Untreatable" Conditions in an Era of Expanded Newborn Screening
Bailey et al.
J Pediatr Psychol 2008;0:jsn032v1-jsn032.
ABSTRACT | FULL TEXT  

Gender dimorphism following injury: making the connection from bench to bedside
Sperry and Minei
J. Leukoc. Biol. 2008;83:499-506.
ABSTRACT | FULL TEXT  

Ethical, Legal, and Social Concerns About Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues
Bailey et al.
Pediatrics 2008;121:e693-e704.
ABSTRACT | FULL TEXT  

Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus
Lu et al.
J. Immunol. 2007;179:6352-6358.
ABSTRACT | FULL TEXT  

Medical Education: What's Relevant, What's Irrelevant, and What's Missing.
Laube
Obstet Gynecol 2006;108:1062-1066.
FULL TEXT  

X inactivation and cellular mosaicism.
Hagerman and Hagerman
JAMA 2006;296:930-931.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2006;332:842-843.
FULL TEXT  

Women's Health--Advances in Knowledge and Understanding
DeAngelis and Glass
JAMA 2006;295:1448-1450.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.